Novel N-(Arylalkyl)indol-3-ylglyoxylamides targeted as ligands of the benzodiazepine receptor : synthesis, biological evaluation, and molecular modeling analysis of the Structure-Activity Relationships.

A series of N-(arylalkyl)indol-3-ylglyoxylylamides (4-8) was synthesized as ligands of the benzodiazepine receptor (BzR) and tested for their ability to displace [3H]flumazenil from bovine brain membranes. The new compounds, bearing a branched (4) or a geometrically constrained benzyl/phenylethyl amide side chain (5-8), represent the continuation of our research on N-benzylindol-3-ylglyoxylylamides 1 (Da Settimo et al., 1996), N¢-phenylindol-3-ylglyoxylohydrazides 2 (Da Settimo et al., 1998), and N-(indol-3-ylglyoxylyl)alanine derivatives 3 (Primofiore et al., 1989). A few indoles belonging to the previously investigated benzylamides 1 and phenylhydrazides 2 were synthesized and tested to enrich the SARs in these two series. The affinities and the GABA ratios of selected compounds for clonal mammalian R1â2ç2, R3â2ç2, and R5â3ç2 BzR subtypes were also determined. It was hypothesized that the reduced flexibility of indoles 4-8 would both facilitate the mapping of the BzR binding cleft and increase the chances of conferring selectivity for the considered receptor subtypes. In the series of indoles 4, the introduction of a methyl group on the benzylic carbon with the R configuration improved affinity of the 5-substituted (5-Cl and 5-NO2) derivatives, whereas it was detrimental for their 5-unsubtituted (5-H) counterparts. All S enantiomers were less potent than the R ones. Replacement of the methyl with hydrophilic substituents on the benzylic carbon lowered affinity. The isoindolinylamide side chain was tolerated if the 5-position was unsubstituted (Ki of 5a ) 123 nM), otherwise affinity was abolished (5b, c). All the 2-indanylamides 6 and (S)-1- indanylamides 8 were devoid of any appreciable affinity. The 5-Cl and 5-NO2 (R)-1-indanylamides 7b (Ki 80 nM) and 7c (Ki 28 nM) were the most potent among the indoles 5-8 geometrically constrained about the side chain. The 5-H (R)-1 indanylamide 7a displayed a lower affinity (Ki 675 nM). The SARs developed from the new compounds, together with those collected from our previous studies, confirmed the hypothesis of different binding modes for 5-substituted and 5-unsubstituted indoles, suggesting that the shape of the lipophilic pocket L1 (notation in accordance with Cook’s BzR topological model) is asymmetric and highlighted the stereoelectronic and conformational properties of the amide side chain required for high potency. Several of the new indoles showed selectivity for the R1â2ç2 subtype compared with the R3â2ç2 and R5â3ç2 subtypes (e.g.: 4t and 7c bind to these three BzR isoforms with Ki values of 14 nM, 283 nM, 239 nM, and 9 nM, 1960 nM, 95 nM, respectively). The GABA ratios close to unity exhibited by all the tested compounds on each BzR subtype were predictive of an efficacy profile typical of antagonists.